NewGenIvf Group Overview
Latest ROE for NewGenIvf Group: 33.89% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow33.89%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
NewGenIvf Group (NIVF) currently reports a ROE of 33.89%. That is above the sector sector average of -4.47%. Use the charts on this page to explore NewGenIvf Group's ROE history and peer comparisons.
NewGenIvf Group's ROE of 33.89% is higher than the its sector sector average of -4.47%. That is roughly 858.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but NewGenIvf Group's current 33.89% should be judged against industry norms (sector average: -4.47%) and against NIVF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 33.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.47%. From there, open related valuation or income-statement pages for NewGenIvf Group, and consider following NIVF for alerts when major investors trade the stock.
